documents: FDA-2022-N-2825-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-N-2825-0001 | FDA | FDA-2022-N-2825 | Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments | Notice | Request for Comments | 2022-11-25T05:00:00Z | 2022 | 11 | 2022-11-25T05:00:00Z | 2023-01-07T04:59:59Z | 2022-12-15T02:00:31Z | 2022-25642 | 0 | 0 | 09000064855005e6 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref